Company intelligence / Profile preview

Wire Science Medical

China

Ownership: Private
Development stage: Other

Overview

Wire Sciences is a leader in vascular intervention surgical robots in China. The company has over 10 years of experience developing robotic platforms that address clinical needs for safer and more standardized vascular interventions. Their technology aims to reduce physician fatigue and radiation exposure while enabling remote multidisciplinary treatment through telemedicine. The company continues to iterate on its products to expand into more complex procedures. No specific clinical trial results are disclosed.

Therapeutic areas: NeurologyCardiovascular
Modalities: DeviceRobotic-assisted intervention systems
Industry: Surgical Medical Devices

Partnerships

Zylox-Tonbridge (strategic investment partnership focused on integrating medical devices with robotic platforms)

Beyond the preview

Go deeper on Wire Science Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wire Science Medical.

Explore the full profile